Shiseido Future Solution Lx Total Radiance Foundation Reviews

SHISEIDO FUTURE SOLUTION LX TOTAL RADIANCE FOUNDATION  I00- octinoxate and titanium dioxide foam
SHISEIDO Futurity SOLUTION Lx Full RADIANCE FOUNDATION  I20- octinoxate and titanium dioxide foam
SHISEIDO Hereafter SOLUTION LX Total RADIANCE FOUNDATION  I40- octinoxate and titanium dioxide cream
SHISEIDO FUTURE SOLUTION LX TOTAL RADIANCE FOUNDATION  I60- octinoxate and titanium dioxide foam
SHISEIDO Time to come SOLUTION LX Full RADIANCE FOUNDATION  B20- octinoxate and titanium dioxide cream
SHISEIDO FUTURE SOLUTION LX Total RADIANCE FOUNDATION  B40- octinoxate and titanium dioxide cream
SHISEIDO Future SOLUTION LX Full RADIANCE FOUNDATION  B60- octinoxate and titanium dioxide cream
SHISEIDO FUTURE SOLUTION LX TOTAL RADIANCE FOUNDATION  O00- octinoxate and titanium dioxide cream
SHISEIDO FUTURE SOLUTION LX TOTAL RADIANCE FOUNDATION  O20- octinoxate and titanium dioxide cream
SHISEIDO Time to come SOLUTION LX TOTAL RADIANCE FOUNDATION  O40- octinoxate and titanium dioxide foam
SHISEIDO Hereafter SOLUTION Threescore Total RADIANCE FOUNDATION  O60- octinoxate and titanium dioxide cream
SHISEIDO AMERICAS CORPORATION

Disclaimer: Most OTC drugs are non reviewed and approved by FDA, however they may exist marketed if they comply with applicable regulations and policies. FDA has non evaluated whether this product complies.

----------

Active ingredients	Purpose
OCTINOXATE 2.nine%	Sunscreen
TITANIUM DIOXIDE 2.9%	Sunscreen

Uses

• helps prevent sunburn
• if used as directed with other sun protection measures (see Directions), decreases the adventure of pare cancer and early pare aging caused by the sun

Warnings

For external apply only

Do not use on damaged or broken peel

When using this product go along out of eyes. Rinse with water to remove.

Stop utilize and ask a doctor if rash occurs

Keep out of reach of children. If production is swallowed, become medical help or contact a Poisonous substance Control Middle correct away.

Directions

For sunscreen use:

• apply liberally 15 minutes before sun exposure
• apply a h2o resistant sunscreen if swimming or sweating
• reapply at least every 2 hours
• Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin crumbling. To decrease this risk, regularly employ a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:
  • limit fourth dimension in the sun, specially from 10 a.m. – 2 p.m.
  • vesture long-sleeve shirts, pants, hats, and sunglasses
• children under half-dozen months: Ask a doctor

Inactive Ingredients

WATER∙DIMETHICONE∙GLYCERIN∙NYLON-12∙SD Alcohol 40-B∙DIETHYLHEXYL SUCCINATE∙PEG-ix POLYDIMETHYLSILOXYETHYL DIMETHICONE∙PEG-10 DIMETHICONE∙CYCLOMETHICONE∙SORBITAN SESQUIISOSTEARATE∙POTASSIUM METHOXYSALICYLATE∙TRIMETHYLSILOXYSILICATE∙PIPERIDINEPROPIONIC ACID∙TOCOPHERYL ACETATE∙DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER∙SODIUM ACETYLATED HYALURONATE∙CAMELLIA SINENSIS Leaf Extract∙ALUMINUM HYDROXIDE∙DISTEARDIMONIUM HECTORITE∙ISODODECANE∙STEARIC Acid∙DIMETHICONE/PEG-10/15 CROSSPOLYMER∙POLYSILICONE-ii∙TRISODIUM EDTA∙SILICA∙BHT∙BARIUM SULFATE∙TOCOPHEROL∙ALCOHOL∙POLYMETHYLSILSESQUIOXANE∙DIPROPYLENE GLYCOL∙SODIUM METABISULFITE∙HYDROGEN DIMETHICONE∙ALUMINA∙PHENOXYETHANOL∙FRAGRANCE∙TITANIUM DIOXIDE∙IRON OXIDES∙MICA∙

Other information

• protect this product in this container from excessive heat and straight sun.

Questions or comments?

Call toll free 1-800-906-7503

Master DISPLAY Panel - 30 mL Jar Carton - I 00

SHowdySouthwardEIDO

I 00

Hereafter SOLUTION LX

Full Radiance Foundation
Broad SPECTRUM SPF 20
SUNSCREEN

30mL NET WT. one OZ.

Principal DISPLAY PANEL - 30 mL Jar Carton - I twenty

Due southHowdySEIDO

I 20

Future SOLUTION LX

Total Radiance Foundation
BROAD SPECTRUM SPF 20
SUNSCREEN

30mL NET WT. 1 OZ.

PRINCIPAL DISPLAY Console - 30 mL Jar Carton - I forty

SHelloDue southEIDO

I 40

FUTURE SOLUTION Sixty

Total Radiance Foundation
Wide SPECTRUM SPF 20
SUNSCREEN

30mL NET WT. 1 OZ.

PRINCIPAL Display Console - 30 mL Jar Carton - I 60

SouthwardHow-do-you-doSEIDO

I 60

Futurity SOLUTION 60

Full Radiance Foundation
BROAD SPECTRUM SPF 20
SUNSCREEN

30mL NET WT. 1 OZ.

Principal DISPLAY Panel - xxx mL Jar Carton - B 20

SHiSEIDO

B 20

Hereafter SOLUTION LX

Total Radiance Foundation
BROAD SPECTRUM SPF 20
SUNSCREEN

30mL NET WT. 1 OZ.

Principal DISPLAY Panel - 30 mL Jar Carton - B 40

Due southHISEIDO

B 40

FUTURE SOLUTION LX

Full Radiance Foundation
BROAD SPECTRUM SPF 20
SUNSCREEN

30mL Internet WT. 1 OZ.

PRINCIPAL DISPLAY Panel - thirty mL Jar Carton - B 60

Due southHow-do-you-doSEIDO

B 60

Hereafter SOLUTION 60

Total Radiance Foundation
BROAD SPECTRUM SPF twenty
SUNSCREEN

30mL NET WT. i OZ.

Principal DISPLAY PANEL - xxx mL Jar Carton - O 00

SouthwardHISEIDO

O 00

Future SOLUTION 60

Full Radiance Foundation
BROAD SPECTRUM SPF 20
SUNSCREEN

30mL NET WT. 1 OZ.

PRINCIPAL DISPLAY PANEL - 30 mL Jar Carton - O twenty

SHISEIDO

O 20

FUTURE SOLUTION LX

Total Radiance Foundation
BROAD SPECTRUM SPF 20
SUNSCREEN

30mL NET WT. ane OZ.

PRINCIPAL DISPLAY PANEL - 30 mL Jar Carton - O 40

SHISouthwardEIDO

O xl

Time to come SOLUTION LX

Total Radiance Foundation
BROAD SPECTRUM SPF xx
SUNSCREEN

30mL NET WT. 1 OZ.

PRINCIPAL Brandish PANEL - thirty mL Jar Carton - O 60

SHowdySouthwardEIDO

O sixty

Future SOLUTION Threescore

Total Radiance Foundation
Broad SPECTRUM SPF twenty
SUNSCREEN

30mL Cyberspace WT. 1 OZ.

SHISEIDO Time to come SOLUTION Lx Full RADIANCE FOUNDATION   I00 octinoxate and titanium dioxide foam

Product Information Production Blazon HUMAN OTC DRUG Detail Code (Source) NDC:58411-225 Route of Administration TOPICAL

Active Ingredient/Active Moiety Ingredient Proper name Ground of Force Forcefulness OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1023 mg  in 30 mL TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 1023 mg  in 30 mL

Inactive Ingredients Ingredient Proper noun Strength Water (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE (UNII: NMQ347994Z) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (M/Q 0.half-dozen-0.8) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC Acrid (UNII: 6L69A7VPHO) .Blastoff.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) Green TEA Leafage (UNII: W2ZU1RY8B0) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) STEARIC Acrid (UNII: 4ELV7Z65AP) EDETATE TRISODIUM (UNII: 420IP921MB) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) ALCOHOL (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) FERRIC OXIDE RED (UNII: 1K09F3G675) FERRIC OXIDE Yellowish (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880)

Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:58411-225-30 1 in 1 CARTON x/01/2014 i 30 mL in 1 JAR; Type 0: Non a Combination Product

Marketing Information Marketing Category Awarding Number or Monograph Citation Marketing Start Date Marketing Finish Date OTC MONOGRAPH Non FINAL part352 10/01/2014

SHISEIDO FUTURE SOLUTION Sixty Full RADIANCE FOUNDATION   I20 octinoxate and titanium dioxide cream

Product Data Product Type HUMAN OTC DRUG Detail Lawmaking (Source) NDC:58411-226 Route of Administration TOPICAL

Agile Ingredient/Active Moiety Ingredient Name Footing of Force Strength OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1023 mg  in 30 mL TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 1023 mg  in 30 mL

Inactive Ingredients Ingredient Name Force Water (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE (UNII: NMQ347994Z) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (G/Q 0.6-0.8) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC ACID (UNII: 6L69A7VPHO) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) GREEN TEA Foliage (UNII: W2ZU1RY8B0) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) STEARIC ACID (UNII: 4ELV7Z65AP) EDETATE TRISODIUM (UNII: 420IP921MB) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .Blastoff.-TOCOPHEROL (UNII: H4N855PNZ1) Alcohol (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.five MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) FERRIC OXIDE Cherry (UNII: 1K09F3G675) FERRIC OXIDE Yellowish (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880)

Packaging # Item Code Packet Description Marketing Commencement Appointment Marketing End Date 1 NDC:58411-226-30 1 in one CARTON 10/01/2014 1 30 mL in 1 JAR; Blazon 0: Not a Combination Production

Marketing Information Marketing Category Application Number or Monograph Commendation Marketing Commencement Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 10/01/2014

SHISEIDO FUTURE SOLUTION LX Total RADIANCE FOUNDATION   I40 octinoxate and titanium dioxide foam

Production Information Production Type Man OTC DRUG Item Code (Source) NDC:58411-227 Road of Administration TOPICAL

Active Ingredient/Active Moiety Ingredient Name Basis of Force Strength OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1023 mg  in 30 mL TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 1023 mg  in 30 mL

Inactive Ingredients Ingredient Name Force WATER (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE (UNII: NMQ347994Z) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (M/Q 0.half-dozen-0.8) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC ACID (UNII: 6L69A7VPHO) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) Greenish TEA Leafage (UNII: W2ZU1RY8B0) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) STEARIC ACID (UNII: 4ELV7Z65AP) EDETATE TRISODIUM (UNII: 420IP921MB) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) ALCOHOL (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) FERRIC OXIDE RED (UNII: 1K09F3G675) FERRIC OXIDE Yellowish (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880)

Packaging # Item Code Package Description Marketing Start Date Marketing Terminate Date 1 NDC:58411-227-xxx 1 in one CARTON 10/01/2014 1 30 mL in 1 JAR; Blazon 0: Not a Combination Production

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 10/01/2014

SHISEIDO Future SOLUTION LX TOTAL RADIANCE FOUNDATION   I60 octinoxate and titanium dioxide foam

Product Information Production Blazon HUMAN OTC DRUG Particular Code (Source) NDC:58411-228 Route of Administration TOPICAL

Active Ingredient/Agile Moiety Ingredient Name Basis of Strength Strength OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1023 mg  in xxx mL TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 1023 mg  in thirty mL

Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-x DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE (UNII: NMQ347994Z) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (One thousand/Q 0.vi-0.eight) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC Acrid (UNII: 6L69A7VPHO) .Blastoff.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) Dark-green TEA Leaf (UNII: W2ZU1RY8B0) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) STEARIC Acid (UNII: 4ELV7Z65AP) EDETATE TRISODIUM (UNII: 420IP921MB) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .Alpha.-TOCOPHEROL (UNII: H4N855PNZ1) ALCOHOL (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.v MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) FERRIC OXIDE RED (UNII: 1K09F3G675) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880)

Packaging # Particular Code Package Description Marketing Commencement Appointment Marketing Cease Engagement 1 NDC:58411-228-xxx 1 in i CARTON 10/01/2014 ane thirty mL in ane JAR; Type 0: Not a Combination Product

Marketing Data Marketing Category Awarding Number or Monograph Citation Marketing Commencement Date Marketing End Date OTC MONOGRAPH Non Terminal part352 ten/01/2014

SHISEIDO FUTURE SOLUTION LX TOTAL RADIANCE FOUNDATION   B20 octinoxate and titanium dioxide cream

Product Information Production Type Homo OTC DRUG Item Code (Source) NDC:58411-229 Route of Administration TOPICAL

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Forcefulness OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1023 mg  in 30 mL TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 1023 mg  in xxx mL

Inactive Ingredients Ingredient Name Force Water (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE (UNII: NMQ347994Z) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (M/Q 0.half dozen-0.viii) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC Acid (UNII: 6L69A7VPHO) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) Light-green TEA LEAF (UNII: W2ZU1RY8B0) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) STEARIC ACID (UNII: 4ELV7Z65AP) EDETATE TRISODIUM (UNII: 420IP921MB) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .Alpha.-TOCOPHEROL (UNII: H4N855PNZ1) Alcohol (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) FERRIC OXIDE RED (UNII: 1K09F3G675) FERRIC OXIDE Yellowish (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880)

Packaging # Particular Code Bundle Description Marketing Start Date Marketing Stop Date 1 NDC:58411-229-30 one in 1 CARTON 10/01/2014 1 30 mL in 1 JAR; Type 0: Not a Combination Product

Marketing Information Marketing Category Application Number or Monograph Citation Marketing First Appointment Marketing End Date OTC MONOGRAPH Non Last part352 10/01/2014

SHISEIDO FUTURE SOLUTION LX TOTAL RADIANCE FOUNDATION   B40 octinoxate and titanium dioxide cream

Product Information Production Blazon HUMAN OTC DRUG Particular Code (Source) NDC:58411-230 Route of Administration TOPICAL

Active Ingredient/Active Moiety Ingredient Name Basis of Force Forcefulness OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1023 mg  in 30 mL TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 1023 mg  in thirty mL

Inactive Ingredients Ingredient Proper noun Force WATER (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE (UNII: NMQ347994Z) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (1000/Q 0.six-0.viii) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC ACID (UNII: 6L69A7VPHO) .Blastoff.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) GREEN TEA LEAF (UNII: W2ZU1RY8B0) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) STEARIC ACID (UNII: 4ELV7Z65AP) EDETATE TRISODIUM (UNII: 420IP921MB) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .Blastoff.-TOCOPHEROL (UNII: H4N855PNZ1) Booze (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) FERRIC OXIDE RED (UNII: 1K09F3G675) FERRIC OXIDE Xanthous (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880)

Packaging # Item Code Package Description Marketing Start Appointment Marketing Finish Date 1 NDC:58411-230-xxx 1 in 1 CARTON 10/01/2014 1 30 mL in 1 JAR; Blazon 0: Not a Combination Product

Marketing Information Marketing Category Application Number or Monograph Commendation Marketing Start Date Marketing Stop Date OTC MONOGRAPH Not Last part352 10/01/2014

SHISEIDO FUTURE SOLUTION LX Total RADIANCE FOUNDATION   B60 octinoxate and titanium dioxide cream

Product Information Product Blazon HUMAN OTC DRUG Particular Code (Source) NDC:58411-231 Route of Administration TOPICAL

Active Ingredient/Active Moiety Ingredient Name Basis of Forcefulness Strength OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1023 mg  in 30 mL TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 1023 mg  in thirty mL

Inactive Ingredients Ingredient Proper noun Force WATER (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE (UNII: NMQ347994Z) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC ACID (UNII: 6L69A7VPHO) .Blastoff.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) Light-green TEA LEAF (UNII: W2ZU1RY8B0) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) STEARIC ACID (UNII: 4ELV7Z65AP) EDETATE TRISODIUM (UNII: 420IP921MB) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) Booze (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) FERRIC OXIDE Red (UNII: 1K09F3G675) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880)

Packaging # Particular Code Package Description Marketing Start Appointment Marketing Cease Date 1 NDC:58411-231-30 1 in 1 CARTON ten/01/2014 ane thirty mL in 1 JAR; Blazon 0: Not a Combination Product

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Showtime Engagement Marketing End Date OTC MONOGRAPH Non FINAL part352 10/01/2014

SHISEIDO FUTURE SOLUTION LX Total RADIANCE FOUNDATION   O00 octinoxate and titanium dioxide cream

Product Information Production Blazon Homo OTC DRUG Item Code (Source) NDC:58411-232 Route of Administration TOPICAL

Agile Ingredient/Agile Moiety Ingredient Proper name Ground of Strength Strength OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1023 mg  in thirty mL TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 1023 mg  in 30 mL

Inactive Ingredients Ingredient Name Force WATER (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) PEG-nine POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE (UNII: NMQ347994Z) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (Thousand/Q 0.6-0.8) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC Acid (UNII: 6L69A7VPHO) .Blastoff.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) GREEN TEA Foliage (UNII: W2ZU1RY8B0) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) STEARIC ACID (UNII: 4ELV7Z65AP) EDETATE TRISODIUM (UNII: 420IP921MB) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) ALCOHOL (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (four.5 MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) FERRIC OXIDE Blood-red (UNII: 1K09F3G675) FERRIC OXIDE Yellow (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880)

Packaging # Item Code Package Description Marketing Start Date Marketing Cease Engagement 1 NDC:58411-232-30 1 in 1 CARTON 10/01/2014 one 30 mL in 1 JAR; Type 0: Not a Combination Production

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Kickoff Date Marketing End Date OTC MONOGRAPH Not FINAL part352 10/01/2014

SHISEIDO FUTURE SOLUTION Lx Total RADIANCE FOUNDATION   O20 octinoxate and titanium dioxide cream

Product Information Product Blazon HUMAN OTC DRUG Particular Code (Source) NDC:58411-233 Route of Administration TOPICAL

Active Ingredient/Active Moiety Ingredient Proper name Footing of Strength Forcefulness OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1023 mg  in 30 mL TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 1023 mg  in 30 mL

Inactive Ingredients Ingredient Proper noun Strength Water (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-x DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE (UNII: NMQ347994Z) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC ACID (UNII: 6L69A7VPHO) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) Green TEA Leaf (UNII: W2ZU1RY8B0) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) STEARIC ACID (UNII: 4ELV7Z65AP) EDETATE TRISODIUM (UNII: 420IP921MB) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) Booze (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) FERRIC OXIDE RED (UNII: 1K09F3G675) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880)

Packaging # Item Lawmaking Bundle Clarification Marketing Start Engagement Marketing Terminate Date i NDC:58411-233-xxx i in one CARTON x/01/2014 ane 30 mL in 1 JAR; Type 0: Non a Combination Product

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Kickoff Date Marketing Stop Date OTC MONOGRAPH Non Concluding part352 x/01/2014

SHISEIDO FUTURE SOLUTION LX TOTAL RADIANCE FOUNDATION   O40 octinoxate and titanium dioxide cream

Production Information Product Blazon Homo OTC DRUG Item Code (Source) NDC:58411-234 Road of Administration TOPICAL

Agile Ingredient/Agile Moiety Ingredient Name Basis of Strength Forcefulness OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1023 mg  in 30 mL TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 1023 mg  in 30 mL

Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-x DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE (UNII: NMQ347994Z) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (Yard/Q 0.6-0.viii) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC Acrid (UNII: 6L69A7VPHO) .Alpha.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) Green TEA Leaf (UNII: W2ZU1RY8B0) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) STEARIC Acrid (UNII: 4ELV7Z65AP) EDETATE TRISODIUM (UNII: 420IP921MB) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .Blastoff.-TOCOPHEROL (UNII: H4N855PNZ1) ALCOHOL (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.five MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) FERRIC OXIDE RED (UNII: 1K09F3G675) FERRIC OXIDE Xanthous (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880)

Packaging # Particular Code Package Description Marketing Beginning Date Marketing End Date ane NDC:58411-234-xxx 1 in 1 CARTON 10/01/2014 1 30 mL in i JAR; Type 0: Not a Combination Production

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing Finish Date OTC MONOGRAPH NOT Final part352 x/01/2014

SHISEIDO FUTURE SOLUTION LX Full RADIANCE FOUNDATION   O60 octinoxate and titanium dioxide cream

Product Information Product Type HUMAN OTC DRUG Particular Code (Source) NDC:58411-235 Route of Administration TOPICAL

Agile Ingredient/Active Moiety Ingredient Name Basis of Strength Force OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1023 mg  in 30 mL TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 1023 mg  in 30 mL

Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE (UNII: NMQ347994Z) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC Acrid (UNII: 6L69A7VPHO) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) GREEN TEA LEAF (UNII: W2ZU1RY8B0) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) STEARIC ACID (UNII: 4ELV7Z65AP) EDETATE TRISODIUM (UNII: 420IP921MB) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .Alpha.-TOCOPHEROL (UNII: H4N855PNZ1) ALCOHOL (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.five MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) FERRIC OXIDE Ruby (UNII: 1K09F3G675) FERRIC OXIDE Yellow (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880)

Packaging # Item Lawmaking Package Clarification Marketing Start Date Marketing Terminate Date 1 NDC:58411-235-xxx ane in 1 CARTON x/01/2014 one xxx mL in 1 JAR; Type 0: Not a Combination Product

Marketing Information Marketing Category Application Number or Monograph Commendation Marketing Start Engagement Marketing End Engagement OTC MONOGRAPH Non Concluding part352 10/01/2014

Labeler -SHISEIDO AMERICAS CORPORATION (193691821)

Establishment
Proper noun	Address	ID/FEI	Business Operations
SHISEIDO AMERICA INC.		782677132	Industry(58411-225, 58411-226, 58411-227, 58411-228, 58411-229, 58411-230, 58411-231, 58411-232, 58411-233, 58411-234, 58411-235) , ANALYSIS(58411-225, 58411-226, 58411-227, 58411-228, 58411-229, 58411-230, 58411-231, 58411-232, 58411-233, 58411-234, 58411-235)

hohmandoperis.blogspot.com

Source: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=beef285c-a73f-4f7c-bc60-14a27ed258de

Bagikan Artikel ini